Ergomed plc Total Voting Rights and Block Listing Return (2516X)
04 Enero 2022 - 1:00AM
UK Regulatory
TIDMERGO
RNS Number : 2516X
Ergomed plc
04 January 2022
Total Voting Rights and Block Listing Return
Total Voting Rights
Guildford, UK - 4 January 2022 : In accordance with the
Financial Conduct Authority's Disclosure Guidance and Transparency
Rules ("DTRs"), Ergomed plc (the "Company") announces the following
information.
The Company's issued share capital as at 31 December 2021
consisted of 49,138,071 ordinary shares of 1p each, none of which
were held in treasury. Each ordinary share in the capital of the
Company carries one voting right.
The above figure may be used by shareholders as the denominator
for the calculations by which they will determine if they are
required to notify their interest in, or a change to their interest
in, the Company, under the DTRs.
Block Listing Six Monthly Return
Name of applicant: Ergomed plc
Name of scheme: Ergomed plc Long Term Incentive Plan
------------------------------------------------------------
Period of return: From: 1 July 2021 To: 31 December 2021
-------------------------- ---------------------- ------- ---------------------------
Balance of unallotted securities under scheme(s) from
previous return: 1,466,400
------------------------------------------------------------
Plus: The amount by which the block scheme(s) has been
increased since the date of the last
return (if any increase has been applied for): 600,000
------------------------------------------------------------
Less: Number of securities issued/allotted under
scheme(s) during period (see LR3.5.7G): 158,223
------------------------------------------------------------
Equals: Balance under scheme(s) not yet issued/allotted
at end of period: 1,908,177
------------------------------------------------------------
Number and class of securities originally admitted and 1,800,000 ordinary shares of 1p each - 2 July 2018
the date of admission 1,500,000 ordinary shares of 1p each - 31 December 2019
600,000 ordinary shares of 1p each - 7 July 2021
------------------------------------------------------------
Total number of securities in issue at the end of the 49,138,071 ordinary shares of 1p each
period
------------------------------------------------------------
Name of contact: Nick Roberts - Head of Group Reporting
Telephone number of contact: +44 (0) 1483 503 205
---------------------------------------
ENDS
Enquiries:
Ergomed plc Tel: +44 (0) 1483 402
975
Miroslav Reljanović (Executive Chairman)
Richard Barfield (Chief Financial Officer)
Numis Securities Limited Tel: +44 (0) 20 7260 1000
Freddie Barnfield / Matthew O'Dowd (Nominated
Adviser)
James Black (Broker)
Consilium Strategic Communications Tel: +44 (0) 20 3709 5700
Chris Gardner / Matthew Neal ergomed@consilium-comms.com
Angela Gray / Lucy Featherstone
About Ergomed plc
Ergomed provides specialist services to the pharmaceutical
industry spanning all phases of clinical development, post-approval
pharmacovigilance and medical information. Ergomed's fast-growing
services business includes an industry-leading suite of specialist
pharmacovigilance (PV) solutions, integrated under the
PrimeVigilance brand and a full range of high-quality clinical
research and trial management services under the Ergomed brand
(CRO). For further information, visit: http://ergomedplc.com .
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
TVRBXLLBLFLXBBD
(END) Dow Jones Newswires
January 04, 2022 02:00 ET (07:00 GMT)
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Mar 2024 a Abr 2024
Ergomed (LSE:ERGO)
Gráfica de Acción Histórica
De Abr 2023 a Abr 2024